The prevalence and impact of bleeding disorders in women is not sufficiently acknowledged, with the organisation of care traditionally biased towards boys and men with haemophilia. In 2017, the European Haemophilia Consortium surveyed women with bleeding disorders, national member organisations (NMOs) and treatment centres to assess the impact of bleeding disorders in women in four domains: physical activity, active life, romantic and social life, and reproductive life. Most women had von Willebrand disease (VWD) or described themselves as a carrier. All reported a negative impact on physical activity, active life and romantic and social life. Up to 70% of women in all groups reported that their bleeding disorder had a significant impact on their ability or willingness to have children, or prevented it. Heavy menstrual bleeding was reported as the having the most significant impact on daily life. Women face barriers to diagnosis and care, including difficulty obtaining a referral and lack of knowledge among general practitioners and gynaecologists. While bleeding disorders share many symptoms, including bleeding after minor injury and trauma, the link between heavy menstrual bleeding and a bleeding disorder often goes unrecognised and its severity is underestimated. Screening is not offered to all eligible women despite the availability of long-established management guidelines; clinical tools to estimate severity may be unreliable. Failure to recognise a bleeding disorder in a woman is a multifactorial problem that is partly due to cultural reluctance to discuss menstruation. Public awareness campaigns are seeking to correct this, and many NMOs involve women in their initiatives and provide women-centred activities. However, a transformation in diagnosis is needed to shift the focus of treatment centres beyond boys and men with haemophilia, and to acknowledge the prevalence and severity of bleeding disorders in women.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Noone D Skouw-Rasmussen N Lavin M van Galen KPM Kadir RA. Barriers and challenges faced by women with congenital bleeding disorders in Europe: Results of a patient survey conducted by the European Haemophilia Consortium. Haemophilia 2019; 25(3): 468-74. doi: 10.1111/hae.13722.
2. World Federation of Hemophilia. WFH Annual Report 2017. Available from http://www1.wfh.org/publications/files/pdf-1696.pdf (accessed 29 May 2019).
3. Jacobson AE Vesely SK Koch T Campbell K O’Brien SH. Patterns of von Willebrand disease screening in girls and adolescents with heavy menstrual bleeding. Obstet Gynecol 2018; 131: 1121-29. doi: 10.1097/AOG.0000000000002620.
4. Lavin M Aguila S Dalton N et al. Significant gynecological bleeding in women with low von Willebrand factor levels. Blood Adv 2018; 2: 1784-91. doi: 10.1182/bloodadvances.2018017418.
5. Committee on Adolescent Health Care Committee on Gynecologic Practice American College of Obstetrics and Gynecology. Committee Opinion No. 580: von Willebrand disease in women. Obstet Gynecol 2013; 122: 1368-73. doi: 10.1097/01.AOG.0000438961.38979.19.